시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 산전 및 신생아 유전자 검사 시장 보고서(2025년)
Prenatal And Newborn Genetic Testing Global Market Report 2025
상품코드 : 1694821
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,156,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 8,898,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,640,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

산전 및 신생아 유전자 검사 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년까지 12.1%의 연평균 복합 성장률(CAGR)로 120억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 유전자 검사 패널의 확대, 임산부의 건강 인식 증가, 산전 및 신생아 선별 검사 가이드라인, 희귀질환에 대한 관심 증가, 윤리적 및 규제적 고려 사항 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 비침습적 산전검사(NIPT), 유전체 시퀀싱(WGS) 및 전체 엑솜 시퀀싱, 인공지능(AI) 통합, 착상 전 유전학적 검사(PGT), 소비자 직접 유전자 검사 등이 있습니다.

산전 검사 및 신생아 유전자 검사에 대한 정부의 이니셔티브와 지원은 당분간 산전 및 신생아 유전자 검사 시장의 성장을 가속할 것으로 예상됩니다. 이러한 노력에는 특정 문제를 해결하거나 시민의 행복을 증진하기 위해 다양한 수준의 정부 기관이 도입하는 특정 행동, 프로그램, 정책 등이 포함됩니다. 정부는 산전 및 신생아 유전자 검사 프로그램을 옹호하고 지원함으로써 임신 중 또는 출생 직후 태아의 유전적 이상 및 상태를 식별하는 데 기여하고 있으며, 2022년 6월 호주 정부가 뉴사우스웨일즈(NSW) 신생아 선별 검사 프로그램에 매년 130만 달러(한화 약 14억 원)를 지원하기로 했습니다. 130만 달러를 지원하기로 한 것이 그 한 예입니다. 이 기금은 중증복합면역결핍증(SCID)과 척수성 근위축증(SMA)에 대한 무료 검사를 촉진하고, 주 내 모든 신생아에게 유전자 검사를 제공하여 연간 10만 명의 신생아 중 13명의 생명을 구할 수 있는 기회를 제공했습니다. 따라서 산전 및 신생아 유전자 검사를 강화하려는 정부의 이니셔티브이 각 검사 시장의 성장을 가속하고 있습니다.

유전성 질환의 발병률 증가는 향후 태아 및 신생아 유전자 검사 시장의 성장을 가속할 것으로 예상됩니다. 유전질환은 개인의 DNA나 유전물질의 이상이나 돌연변이로 인해 발생하는 병입니다. 산전 및 신생아 유전자 검사는 이러한 질병을 조기에 발견할 수 있으며, 많은 경우 증상이 나타나기 전에 발견할 수 있기 때문에 의료 서비스 제공업체가 적시에 개입 및 치료 전략을 시행할 수 있습니다. 예를 들어, 2024년 5월 미국 질병통제예방센터(CDC)는 미국에서 겸상적혈구증(SCD) 환자가 약 10만 명에 달한다고 보고했습니다. 환자 중 90% 이상이 비히스패닉계 흑인 또는 아프리카계 미국인이며, 히스패닉계 또는 라틴계 미국인은 3%-9%로 추정됩니다. 이처럼 유전성 질환의 유병률 증가는 산전 및 신생아 유전자 검사 시장의 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Prenatal and newborn genetic testing encompasses medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are crucial for detecting and identifying genetic disorders, congenital conditions, or hereditary diseases that may impact the child's health or development.

The primary product types within the prenatal and newborn genetic testing domain include consumables and instruments. Instruments refer to specialized tools or devices designed for specific tasks or measurements, including various genetic analyzers used by healthcare professionals to conduct screenings and tests. Various screening methods include non-invasive prenatal testing, chronic villus sampling, amniocentesis, maternal serum screening, and others. The tests aim to identify diseases such as Down syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. These genetic testing products find application across diverse end-users, including hospitals, maternity and specialty clinics, and diagnostic centers.

The prenatal and newborn genetic testing market research report is one of a series of new reports from The Business Research Company that provides prenatal and newborn genetic testing market statistics, including prenatal and newborn genetic testing industry global market size, regional shares, competitors with a prenatal and newborn genetic testing market share, detailed prenatal and newborn genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal and newborn genetic testing industry. This prenatal and newborn genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal and newborn genetic testing market size has grown rapidly in recent years. It will grow from $6.68 billion in 2024 to $7.61 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to improved non-invasive prenatal testing, increased maternal age, government support and healthcare policies, patient demand for early detection.

The prenatal and newborn genetic testing market size is expected to see rapid growth in the next few years. It will grow to $12.04 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to expanded genetic test panels, increasing maternal health awareness, prenatal and newborn screening guidelines, rising focus on rare diseases, ethical and regulatory considerations. Major trends in the forecast period include non-invasive prenatal testing (NIPT), genome sequencing (WGS) and whole exome sequencing, integration of artificial intelligence (AI), preimplantation genetic testing (PGT), direct-to-consumer genetic testing.

Government initiatives and backing for prenatal testing and newborn genetic screening are anticipated to propel the expansion of the prenatal and newborn genetic testing markets in the foreseeable future. Such initiatives encompass specific actions, programs, or policies introduced by governmental bodies at various levels to address particular issues or promote the well-being of citizens. By advocating for and supporting prenatal and newborn genetic testing programs, governments contribute to the identification of genetic abnormalities or conditions in fetuses during pregnancy or shortly after birth. An illustration of this is seen in the Australian government's allocation of $1.3 million annually to the New South Wales (NSW) newborn screening program in June 2022. This funding facilitated free testing for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), providing genetic screening to all newborns in the state and potentially saving the lives of 13 infants with these genetic disorders among the 100,000 babies born yearly. Hence, government initiatives fortifying prenatal and newborn genetic screening drive the growth of the respective testing markets.

The rising incidence of genetic disorders is anticipated to drive growth in the prenatal and newborn genetic testing market in the future. Genetic disorders are medical conditions caused by abnormalities or mutations in an individual's DNA or genetic material. Prenatal and newborn genetic testing enables the early identification of these disorders, often before symptoms appear, allowing healthcare providers to implement timely interventions and treatment strategies. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that sickle cell disease (SCD) affects approximately 100,000 individuals in the United States. Among those affected, over 90% are non-Hispanic Black or African American, while an estimated 3%-9% are Hispanic or Latino. Thus, the increasing prevalence of genetic disorders is propelling the growth of the prenatal and newborn genetic testing market.

Leading companies in the prenatal and newborn genetic testing sectors are concentrating on developing innovative screening tests, particularly noninvasive prenatal screening tests, to enhance accessibility and affordability while ensuring dependable services for customers. Noninvasive prenatal screening (NIPS) or noninvasive prenatal testing (NIPT) represents an advanced and secure genetic screening method conducted during pregnancy to evaluate the risk of specific fetal chromosomal abnormalities. An instance of this advancement is Juno Diagnostics Inc.'s introduction of Juno Hazel in November 2022. This noninvasive prenatal screening test identifies chromosomal anomalies and offers clinical content using a sample collection kit, eliminating the necessity for phlebotomy and enhancing accessibility. Additionally, the company intends to provide educational resources and personalized genetic counseling support by partnering with healthcare professionals and genetic counselors.

In February 2024, CooperSurgical Inc., a US-based medical equipment manufacturing company, formed a partnership with Fulgent Genetics to enhance its offerings in the prenatal and newborn genetic testing market. This collaboration aims to leverage Fulgent Genetics' expertise in advanced genetic testing solutions, particularly for families using the Cord Blood Registry. Fulgent Genetics Inc. specializes in providing a range of prenatal and newborn genetic testing services, which aligns with CooperSurgical's goals of expanding its portfolio and improving access to critical genetic testing options for expectant families.

Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal and newborn genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The prenatal and newborn genetic testing market consists of revenues earned by entities by providing services such as prenatal screening tests, prenatal diagnostic tests, carrier screening for genetic conditions, and newborn screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The prenatal and newborn genetic testing market also includes sales of electrophoresis equipment, genetic sequencing machines, and microarray analysis instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal And Newborn Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal and newborn genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for prenatal and newborn genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prenatal and newborn genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Prenatal And Newborn Genetic Testing Market Characteristics

3. Prenatal And Newborn Genetic Testing Market Trends And Strategies

4. Prenatal And Newborn Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Prenatal And Newborn Genetic Testing Growth Analysis And Strategic Analysis Framework

6. Prenatal And Newborn Genetic Testing Market Segmentation

7. Prenatal And Newborn Genetic Testing Market Regional And Country Analysis

8. Asia-Pacific Prenatal And Newborn Genetic Testing Market

9. China Prenatal And Newborn Genetic Testing Market

10. India Prenatal And Newborn Genetic Testing Market

11. Japan Prenatal And Newborn Genetic Testing Market

12. Australia Prenatal And Newborn Genetic Testing Market

13. Indonesia Prenatal And Newborn Genetic Testing Market

14. South Korea Prenatal And Newborn Genetic Testing Market

15. Western Europe Prenatal And Newborn Genetic Testing Market

16. UK Prenatal And Newborn Genetic Testing Market

17. Germany Prenatal And Newborn Genetic Testing Market

18. France Prenatal And Newborn Genetic Testing Market

19. Italy Prenatal And Newborn Genetic Testing Market

20. Spain Prenatal And Newborn Genetic Testing Market

21. Eastern Europe Prenatal And Newborn Genetic Testing Market

22. Russia Prenatal And Newborn Genetic Testing Market

23. North America Prenatal And Newborn Genetic Testing Market

24. USA Prenatal And Newborn Genetic Testing Market

25. Canada Prenatal And Newborn Genetic Testing Market

26. South America Prenatal And Newborn Genetic Testing Market

27. Brazil Prenatal And Newborn Genetic Testing Market

28. Middle East Prenatal And Newborn Genetic Testing Market

29. Africa Prenatal And Newborn Genetic Testing Market

30. Prenatal And Newborn Genetic Testing Market Competitive Landscape And Company Profiles

31. Prenatal And Newborn Genetic Testing Market Other Major And Innovative Companies

32. Global Prenatal And Newborn Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prenatal And Newborn Genetic Testing Market

34. Recent Developments In The Prenatal And Newborn Genetic Testing Market

35. Prenatal And Newborn Genetic Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기